Abstract

Chronic inflammatory airway diseases, such as asthma, are prevalent among children and significantly impact their quality of life. These conditions are characterized by persistent airway inflammation, hyperresponsiveness, and airflow obstruction. This article provides a comprehensive review of the underlying mechanisms, clinical manifestations, diagnostic challenges, and therapeutic strategies for chronic airway inflammation in children. Key treatments include inhaled corticosteroids, bronchodilators, and biologics, while future directions emphasize personalized medicine and early intervention to prevent disease progression. The article also addresses the role of environmental factors and early-life exposures in the development of these diseases.